Aloxi

Helsinn Healthcare in settlement agreement with Dr Reddy's

 Helsinn Healthcare SA, a Switzerland-based pharma company, today said it has entered into a settlement agreement with Dr Reddy's Laboratories to resolve certain patent litigations relating to the former's drug Aloxi (palonosetron HCl injection) in the United States.

Oct 13, 2015, 15:04 PM IST